FDA-Drug2026-03-11Class IIPROCESSING DEFECT
New Life Pharma Tirzepatide injection recalled for sterility concerns
OTHEROH
Stop using New Life Pharma Tirzepatide injection
New Life Pharma LLC is recalling Tirzepatide 10mg multi-dose vials (Lot 240709, expiration 7/31/2026) because the manufacturer cannot confirm the product is sterile. The vials were distributed in Ohio. No injuries have been reported.
- Check if you have Tirzepatide from New Life Pharma with Lot 240709
- Do not use the recalled vials
- Contact your pharmacy or healthcare provider for a replacement or alternative
Hazard
Lack of Assurance of Sterility
Sold states
OH
Affected count
23 vials
Manufactured in
265 Livingston St, N/A, Northvale, NJ, United States
Products
Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-03.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0394-2026Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief